桂枝茯苓丸抑制子宫内膜异位症的关键组分研究
本研究在C57BL/6NCrlBltw小鼠诱导子宫内膜异位症模型上,通过单味药及序贯剔除桂枝、茯苓等组分处理28天,结合免疫组化与蛋白印迹检测炎症及凋亡标志物。结果显示剔除桂枝或茯苓均削弱全方抑制内膜异位症的作用,而单用桂枝、茯苓或桃仁仍具抑制效果;桂枝与茯苓为全方中最为关键的君药组分,桃仁为臣药。
要点
- 桂枝与茯苓是桂枝茯苓丸抑制子宫内膜异位症的关键君药组分。
- 单用桂枝、茯苓或桃仁均可抑制子宫内膜异位症发展。
- 剔除桂枝或茯苓会削弱全方降低ICAM-1和提升caspase-3的作用。
核心结论
- 剔除桂枝或茯苓会减弱桂枝茯苓丸对子宫内膜异位症发展的抑制作用,而单用桂枝或茯苓仍维持该抑制效果。
- 桂枝和茯苓是桂枝茯苓丸治疗子宫内膜异位症最关键的组分,对应全方中的君药;桃仁为臣药。
研究设计与样本
- 在C57BL/6NCrlBltw小鼠中诱导子宫内膜异位症,分别给予水、桂枝茯苓丸、全方各单味药及序贯剔除单味药的桂枝茯苓丸处理28天。
- 采用免疫组化和蛋白印迹法检测炎症与凋亡标志物的表达。
主要发现
- 剔除桂枝或茯苓均降低桂枝茯苓丸抑制子宫内膜异位症的效果。
- 单用桂枝、茯苓或桃仁均可抑制子宫内膜异位症的发展。
- 桂枝茯苓丸降低ICAM-1的作用在剔除桂枝、茯苓或桃仁后减弱,而单用桂枝或茯苓可降低ICAM-1表达。
- 剔除桂枝或茯苓减弱桂枝茯苓丸对caspase-3的上调,而单用桂枝或茯苓可升高caspase-3表达。
关键数值与推荐
- 剔除桂枝或茯苓后桂枝茯苓丸抑制子宫内膜异位症的效果降低;单用桂枝、茯苓或桃仁均显示抑制效果。
- 桂枝茯苓丸降低ICAM-1的作用在剔除桂枝、茯苓或桃仁后减弱;单用桂枝或茯苓降低ICAM-1表达。
- 桂枝茯苓丸上调caspase-3的作用在剔除桂枝或茯苓后减弱;单用桂枝或茯苓升高caspase-3表达。
临床怎么用
- 在子宫内膜异位症的中医治疗中,可重视桂枝与茯苓作为君药的核心地位。
- 组方时保留桂枝、茯苓可能有助于维持全方抑制子宫内膜异位症的效果。
- 桃仁作为臣药,单用亦显示抑制子宫内膜异位症的作用。
局限性
- 研究仅在小鼠模型中进行,尚未在人体验证。
- 未报告剂量、样本量及统计学显著性数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Endometriosis is a common gynecological disorder that manifests as chronic pelvic pain and subfertility. Guizhi Fuling Wan (GFW), which contains five herbs, was first described in Chinese canonical medicine to treat qi stagnation and circulation. Although the inhibition of endometriosis by GFW has been previously demonstrated, its efficacy could potentially be improved by adjusting the dose of each component. AIM: This study aimed to examine the relative importance of herbs in endometriosis treatment. MATERIALS AND METHODS: Endometriosis was induced in C57BL/6NCrlBltw mice, followed by treatment with H2O, GFW, all individual herbs of GFW, and GFW with sequential deletion of a single herb for 28 days. Immunohistochemistry and western blotting were performed to examine the expression of inflammatory and apoptotic markers. RESULTS: The endometriosis-inhibiting effect of GFW was reduced by deletion of either Guizhi or Fuling. Guizhi, Fuling, or Taoren alone also inhibit the development of endometriosis. The reduction in intercellular adhesion molecule 1 (ICAM-1) by GFW was attenuated by deletion of Guizhi, Fuling, or Taoren, whereas either Guizhi or Fuling alone decreased ICAM-1 expression. The deletion of either Guizhi or Fuling diminished the enhancement of caspase-3 by GFW, whereas caspase-3 expression was elevated by either Guizhi or Fuling alone. CONCLUSION: Deletion of either Guizhi or Fuling attenuated the inhibition of endometriosis development, while either Guizhi or Fuling alone maintained the endometriosis-inhibiting effect of GFW. Consistent with the description in the canonical literature of traditional Chinese medicine, this study revealed that Guizhi and Fuling are the most crucial components of GFW in treating endometriosis, as they are the emperor drugs of this formula, whereas Taoren is a minister drug.
引用
- Chen CC, Huang CY, Yu YC, et al. The crucial component(s) of Guizhi Fuling Wan in inhibiting endometriosis development. J Ethnopharmacol. 2024. PMID: 39522847. doi:10.1016/j.jep.2024.119067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。